Ownership

Timothy Sullivan

Insider Reports History

Entity: Individual
Location: 800 Boylston St., Suite 3310, Prudential Tower C/O Aju Ib Investment, Boston, MA
Signature: /s/s David Watson, attorney-in-fact for Timothy Sullivan
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Sullivan:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Apellis Pharmaceuticals, Inc.	Chief Financial Officer	Stock Option (Right to Buy)	84.9K	$5.63M	$66.30	Dec 31, 2024	Direct
Apellis Pharmaceuticals, Inc.	Chief Financial Officer	Common Stock	129K	$3.8M	$29.52	Jan 29, 2025	Direct
Apellis Pharmaceuticals, Inc.	Chief Financial Officer	Common Stock	70.4K	$2.08M	$29.52	Jan 29, 2025	The Timothy E Sullivan Irrevocable Trust of 2023

Previous1Next

Showing 1 to 3 of 3 entries

Insider Reports Filed by Timothy Sullivan

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
APLS	Apellis Pharmaceuticals, Inc.	Jan 29, 2025	1	-$16.1K	4	Jan 30, 2025	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 22, 2025	1	-$94K	4	Jan 23, 2025	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 17, 2025	2	-$51.8K	4	Jan 21, 2025	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 13, 2025	1	-$62.3K	4	Jan 14, 2025	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Dec 31, 2024	4	$155K	4	Jan 3, 2025	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Apr 18, 2024	2	$0	4	Apr 19, 2024	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Apr 1, 2024	3	-$195K	4	Apr 2, 2024	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Mar 1, 2024	4	-$319K	4	Mar 5, 2024	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Feb 12, 2024	1	-$97K	4	Feb 13, 2024	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 29, 2024	1	-$58.1K	4	Jan 31, 2024	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 22, 2024	1	-$231K	4	Jan 23, 2024	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 16, 2024	3	$2.14M	4	Jan 17, 2024	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Nov 30, 2023	4	-$633K	4	Dec 1, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jul 3, 2023	5	-$542K	4	Jul 6, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jun 5, 2023	6	-$5.5M	4	Jun 6, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	May 3, 2023	2	$0	4	May 3, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Apr 19, 2023	2	$0	4	Apr 20, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Feb 21, 2023	3	-$57K	4	Feb 22, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Feb 10, 2023	1	-$49.9K	4	Feb 14, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 27, 2023	1	-$29.1K	4	Jan 30, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 20, 2023	1	-$124K	4	Jan 24, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Apr 25, 2022	4	$2.27M	4	Jan 17, 2023	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Feb 10, 2022	1	-$41.2K	4	Feb 14, 2022	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 28, 2022	1	-$25.1K	4	Feb 1, 2022	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jan 21, 2022	2	$0	4	Jan 25, 2022	Chief Financial Officer
APLS	Apellis Pharmaceuticals, Inc.	Jun 8, 2021	2	$400K	4	Jun 9, 2021	Chief Financial Officer